Bristol-Myers Squibb Co 2019 Annual Report
The report describes 2019 as transformative following the Celgene acquisition, reports total revenues of $26,145 million, and highlights an 18% absolute GHG reduction against a 5% goal. It also identifies a zero-waste-to-landfill and 100% green energy manufacturing facility and diversity resource groups with more than 11,000 global members.
Company: Bristol-Myers Squibb Co
Sector: Manufacturing
Country: United States
Year: 2019
Type: Annual Report
Pages: 112
Back to company
Bristol-Myers Squibb Co
Annual Report
The report describes 2019 as transformative following the Celgene acquisition, reports total revenues of $26,145 million, and highlights an 18% absolute GHG reduction against a 5% goal. It also identifies a zero-waste-to-landfill and 100% green energy manufacturing facility and diversity resource groups with more than 11,000 global members.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Type
Annual Report
Language
English
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available